Encapsulated cell therapy for local anti-CTLA-4 delivery in cancer immunotherapy
Adrien Engel, Remi Vernet, Emily Charrier, Muriel Urwyler, Olivier Von Rohr, Valentin Saingier, Fabien Courtout, Sarah Abukscem, Thomas Bouvarel, Aurelien Lathuiliere, Davy Guillarme, Nicolas Mach, Julien Grogg · 2026
Read Encapsulated cell therapy for local anti-CTLA-4 delivery in cancer immunotherapy by Adrien Engel, Remi Vernet, Emily Charrier, Muriel Urwyler, Olivier Von Rohr, Valentin Saingier, Fabien Courtout, Sarah Abukscem, Thomas Bouvarel, Aurelien Lathuiliere, Davy Guillarme, Nicolas Mach, Julien Grogg (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13427557.txt.
Description
Adrien Engel and co-authors describe, in 2026, a device that makes a cancer drug right next to a tumor instead of flooding the whole body. Drugs that block CTLA-4, a brake on immune cells, can shrink tumors but often cause harsh side effects elsewhere. Their device holds living human muscle cells inside a hollow fiber that can later be removed. The cells release small amounts of the drug where the device sits.
In mice with colon tumors, devices placed near the tumor slowed its growth and helped the animals live longer. Drug levels in the rest of the body stayed far below those from standard injections. Early immune changes inside the tumor matched what the drug should do. Longer safety testing is still ahead.
Catalog record
| CREATOR | Adrien Engel, Remi Vernet, Emily Charrier, Muriel Urwyler, Olivier Von Rohr, Valentin Saingier, Fabien Courtout, Sarah Abukscem, Thomas Bouvarel, Aurelien Lathuiliere, Davy Guillarme, Nicolas Mach, Julien Grogg |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |